A slow valproate-to-lamotrigine cross-taper, watching for rash and early mania, readies a composite teacher with bipolar I for pregnancy in NU675's Unit 3 plan. Searches like "nu 675 unit 3 assignment example", "nu675 unit 3 sample" and "nu675 unit 3 example" land here.
What a finished NU675 Unit 3 medication switch plan looks like
A timeline table and three pages of rationale. The rationale opens with why valproate must go before conception: its boxed warning on fetal harm, including neural tube defects, and the FDA's 2013 safety communication on lower IQ scores in exposed children. Lamotrigine is chosen for her depression-predominant course, with its weaker protection against mania stated plainly and lithium named as the alternative considered. The table runs in phases across [roughly three months]: lamotrigine started on the label's slower schedule for patients taking valproate, valproate reduced in steps once the lamotrigine target is reached, then lamotrigine adjusted upward as the interaction fades, every figure bracketed. A watch column sits beside each phase, listing rash, early signs of mania, sedation and tremor. Coordination with her obstetric clinician and a note on folic acid close the plan.
How a NU675 Unit 3 example is structured
The plan is built as phases, each with an entry condition, the change made, what is watched and what would pause the next step. That shape exists because the overlap is where this switch goes wrong. While both drugs are present, lamotrigine concentrations run high, which is why the starting schedule is the label's reduced one and why any rash during this window prompts same-day review rather than a wait-and-see. As valproate falls, her protection against mania thins, so the watch column shifts toward sleep, speech and spending, using the early signs her own history supplies. No phase advances on the calendar alone; each needs the previous one to have passed quietly. A final section addresses what changes if she conceives earlier than planned, and why the switch should be complete, with a stable interval, before attempts begin.
Why the current drug has to go
Valproate's fetal risks are stated with their sources and dates, and the plan says why they outweigh three years of stability for a woman planning pregnancy. Continuing unchanged is treated as an option considered and rejected, not ignored.
Choosing the destination
Lamotrigine suits a course dominated by depression, and the plan says so. It also says what lamotrigine does less well, preventing mania, and why lithium, with its own pregnancy considerations, was weighed and set aside for now.
The interaction that sets the pace
Valproate slows lamotrigine's clearance, roughly doubling its levels. The plan uses the label's reduced titration while both are present and explains that rushing this stage raises the risk of serious rash, the harm the whole schedule is designed around.
A watch column for each phase
Rash, sleep loss, pressured speech, spending and sedation appear beside the phases where each is likeliest. Her previous manic episode began with [three nights of little sleep], so that sign is listed first as valproate is withdrawn.
Hand-offs before conception
Her obstetric clinician receives the timeline, the plan for folic acid and a note that lamotrigine clearance usually rises in pregnancy, so levels may need watching. The switch is written to finish, with a stable interval, before she stops contraception.
Where marks go in NU675 Unit 3
Switch plans on this unit are graded on the overlap, and the costliest version stops valproate and starts lamotrigine on the same day, or starts lamotrigine at the ordinary schedule while valproate is still present. Graders treat either as a safety error, because the interaction is on the label. A plan that never explains why valproate is leaving also falls short; the fetal risk needs its sources and dates. Choosing lamotrigine without admitting its weaker effect against mania draws comment, as does a watch list with no link to her own early signs. Graders expect the obstetric clinician involved before conception, not after. Unbracketed doses, a schedule advancing by date regardless of symptoms and no mention of how pregnancy changes lamotrigine levels round out the usual deductions.
Get a NU675 Unit 3 example written to your instructions
Tell us the two agents your NU675 Unit 3 case switches between, or that the choice is yours, and forward the case, history included, with the rubric. The first custom plan is free within 24-48h, laid out in phases with a watch column and a pause rule for each, and every figure bracketed.
NU675 Unit 3 questions, answered
How long should a switch plan take?
As long as the drugs involved require, which the plan should explain rather than assert. Interactions, the need to titrate slowly and the risk of losing protection during the overlap all set the pace. Present the timeline in phases with conditions for moving on, and note that a phase can be extended if symptoms appear. Keep specific figures bracketed as composite.
Should the plan consider stopping medication before pregnancy instead of switching?
It should mention it, since some patients ask, and explain why it was or was not chosen. For bipolar I disorder with past mania, stopping carries a substantial risk of relapse, and the postpartum period adds more. Weigh that against fetal exposure, cite the sources you use, and involve the obstetric clinician in the reasoning.
What makes a watch list specific enough?
Tie each item to a phase and a response. Rash during titration means same-day review; two nights of little sleep as the older drug is withdrawn means a call to the prescriber. Draw early signs from the documented history where the case supplies it, since a generic list of mania symptoms tells the reader little about this person.